Search

everythinglearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Young rats are better for testing hair loss treatments after chemotherapy.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

New methods using biomaterials, stem cells, and nanoparticles show promise for improving hair growth and treating hair loss.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

Vitamin A affects hair loss and immune response in alopecia areata.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.